CD3E and acute lymphoblastic leukemia: This approach, based on a second-generation anti-CD3ε CAR that incorporates a 4-1BB costimulatory domain, showed specific cytotoxicity against CD3+ primary T cells and childhood T-ALL samples in vitro.